SYNCOM FORMULATIONS (INDIA)
Back to Cashflow Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹23 Cr | ₹-5.96 Cr | ₹11 Cr | ₹16 Cr | ₹14 Cr |
What is the latest Cash Flow from Operating Activities ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹-5.96 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹16 Cr |
| Mar2017 | ₹14 Cr |
How is Cash Flow from Operating Activities of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹23 Cr | Positive | |
| Mar2024 | ₹-5.96 Cr | Negative | |
| Mar2023 | ₹11 Cr | -35.52 | |
| Mar2022 | ₹16 Cr | 17.98 | |
| Mar2017 | ₹14 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,252.1 Cr | -3.2% | 7.5% | -25.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,613.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,105.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,926.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,088.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
| CIPLA | ₹107,120.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -3.2% |
7.5% |
-25.4% |
| SENSEX | 0% |
1.2% |
9.7% |
You may also like the below Video Courses